HDAC9 and neoplasm: While originally recognized for decreasing gene expression by deacetylating histones, thus leading to a closed chromatin state, altered acetylation states and aberrantly overexpressed HDACs have been found in multiple tumor types, ultimately leading to the use of HDAC inhibitors (HDACi) to treat cancer patients (1).